Please assess the completion status of the following clinical trial:

Trial Title: Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with bilateral cataracts with planned cataract removal by phacoemulsification with a clear cornea incision~* Able to comprehend and willing to sign informed consent and complete all required postoperative follow-up procedures~* Clear intraocular media other than cataract in both eyes.~* Preoperative keratometric astigmatism of less than 1.0 diopter (D) in both operative eyes.~Exclusion Criteria:~* Clinically significant corneal abnormalities including corneal dystrophy, irregularity, inflammation or edema~* Previous refractive surgery or refractive surgery procedures (including, but not limited to LASIK, astigmatic keratotomy, and limbal relaxing incisions)~* Glaucoma (uncontrolled or controlled with medication)~* Degenerative eye disorders (e.g. macular degeneration or other retinal disorders)~* Pregnant or lactating~* Expected to require a second surgical intervention or retinal laser treatment.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multifocal IOL (Type: EXPERIMENTAL): AcrySof IQ PanOptix Multifocal IOL Model TFNT00 implanted in the capsular bag in the posterior chamber following cataract removal and intended for long-term use over the lifetime of the cataract patient. Both eyes will be implanted (bilateral implantation).
- Monofocal IOL (Type: ACTIVE_COMPARATOR): AcrySof Monofocal IOL Model SN60AT implanted in the capsular bag in the posterior chamber following cataract removal and intended for long-term use over the lifetime of the cataract patient. Both eyes will be implanted (bilateral implantation).

Based on this trial design, predict the completion outcome and termination type (if applicable).